Machiels Alec has filed 45 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 7961 shares of Apellis Pharmaceuticals, Inc. ($APLS) on January 01, 2026.
Activity breakdown: 0 open-market purchases and 11 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 1, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | A | Common Stock | 7961 | $0.00 | 796,939.0000 | 130,067,000 | 1.01% | 0.01% |
| Jan. 1, 2026 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | A | Stock Option (Right to Buy) | 14684 | $0.00 | 14,684.0000 | 130,067,000 | 9999.99% | 0.01% |
| Jan. 1, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | A | Common Stock | 6267 | $0.00 | 788,978.0000 | 123,905,000 | 0.80% | 0.01% |
| Jan. 1, 2025 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | A | Stock Option (Right to Buy) | 11199 | $0.00 | 11,199.0000 | 123,905,000 | 9999.99% | 0.01% |
| Jan. 1, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | A | Common Stock | 3341 | $0.00 | 782,711.0000 | 118,678,000 | 0.43% | 0.00% |
| Jan. 1, 2024 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | A | Stock Option (Right to Buy) | 5748 | $59.86 | 5,748.0000 | 118,678,000 | 9999.99% | 0.00% |
| Nov. 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Stock Option (Right to Buy) | 1250 | $0.00 | 0.0000 | 106,114,000 | 100.00% | 0.00% |
| Nov. 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | S | Common Stock | 1250 | $47.74 | 779,370.0000 | 106,114,000 | 0.16% | 0.00% |
| Nov. 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Common Stock | 1250 | $2.67 | 780,620.0000 | 106,114,000 | 0.16% | 0.00% |
| Oct. 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Stock Option (Right to Buy) | 1250 | $0.00 | 1,250.0000 | 106,114,000 | 50.00% | 0.00% |
| Oct. 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Common Stock | 1250 | $2.67 | 780,620.0000 | 106,114,000 | 0.16% | 0.00% |
| Oct. 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | S | Common Stock | 1250 | $48.50 | 779,370.0000 | 106,114,000 | 0.16% | 0.00% |
| Sept. 18, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Stock Option (Right to Buy) | 1250 | $0.00 | 2,500.0000 | 106,114,000 | 33.33% | 0.00% |
| Sept. 18, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Common Stock | 1250 | $2.67 | 780,620.0000 | 106,114,000 | 0.16% | 0.00% |
| Sept. 18, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | S | Common Stock | 1250 | $45.00 | 779,370.0000 | 106,114,000 | 0.16% | 0.00% |
| Sept. 15, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Common Stock | 1250 | $2.67 | 780,620.0000 | 106,114,000 | 0.16% | 0.00% |
| Sept. 15, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | S | Common Stock | 1250 | $45.34 | 779,370.0000 | 106,114,000 | 0.16% | 0.00% |
| Sept. 15, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Stock Option (Right to Buy) | 1250 | $0.00 | 3,750.0000 | 106,114,000 | 25.00% | 0.00% |
| July 21, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Stock Option (Right to Buy) | 49779 | $0.00 | 5,000.0000 | 106,114,000 | 90.87% | 0.05% |
| July 21, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Common Stock | 49779 | $2.67 | 779,370.0000 | 106,114,000 | 6.82% | 0.05% |
| July 20, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Common Stock | 50000 | $2.67 | 729,591.0000 | 106,114,000 | 7.36% | 0.05% |
| July 20, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Stock Option (Right to Buy) | 50000 | $0.00 | 54,779.0000 | 106,114,000 | 47.72% | 0.05% |
| July 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Stock Option (Right to Buy) | 1250 | $0.00 | 104,779.0000 | 106,114,000 | 1.18% | 0.00% |
| July 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Common Stock | 1250 | $2.67 | 680,841.0000 | 106,114,000 | 0.18% | 0.00% |
| July 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | S | Common Stock | 1250 | $64.79 | 679,591.0000 | 106,114,000 | 0.18% | 0.00% |
| June 20, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Stock Option (Right to Buy) | 1250 | $0.00 | 106,029.0000 | 106,114,000 | 1.17% | 0.00% |
| June 20, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | S | Common Stock | 1250 | $88.41 | 679,591.0000 | 106,114,000 | 0.18% | 0.00% |
| June 20, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Common Stock | 1250 | $2.67 | 680,841.0000 | 106,114,000 | 0.18% | 0.00% |
| May 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Stock Option (Right to Buy) | 1250 | $0.00 | 107,279.0000 | 106,114,000 | 1.15% | 0.00% |
| May 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Common Stock | 1250 | $2.67 | 680,841.0000 | 106,114,000 | 0.18% | 0.00% |
| May 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | S | Common Stock | 1250 | $88.66 | 679,591.0000 | 106,114,000 | 0.18% | 0.00% |
| April 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Stock Option (Right to Buy) | 1250 | $0.00 | 108,529.0000 | 106,114,000 | 1.14% | 0.00% |
| April 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Common Stock | 1250 | $2.67 | 680,841.0000 | 106,114,000 | 0.18% | 0.00% |
| April 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | S | Common Stock | 1250 | $81.05 | 679,591.0000 | 106,114,000 | 0.18% | 0.00% |
| March 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Stock Option (Right to Buy) | 1250 | $0.00 | 109,779.0000 | 106,114,000 | 1.13% | 0.00% |
| March 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Common Stock | 1250 | $2.67 | 680,841.0000 | 106,114,000 | 0.18% | 0.00% |
| March 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | S | Common Stock | 1250 | $64.03 | 679,591.0000 | 106,114,000 | 0.18% | 0.00% |
| Feb. 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Stock Option (Right to Buy) | 1250 | $0.00 | 111,029.0000 | 106,114,000 | 1.11% | 0.00% |
| Feb. 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Common Stock | 1250 | $2.67 | 680,841.0000 | 106,114,000 | 0.18% | 0.00% |
| Feb. 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | S | Common Stock | 1250 | $52.38 | 679,591.0000 | 106,114,000 | 0.18% | 0.00% |
| Jan. 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Stock Option (Right to Buy) | 1250 | $0.00 | 112,279.0000 | 106,114,000 | 1.10% | 0.00% |
| Jan. 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | M | Common Stock | 1250 | $2.67 | 680,841.0000 | 106,114,000 | 0.18% | 0.00% |
| Jan. 17, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | S | Common Stock | 1250 | $52.42 | 679,591.0000 | 106,114,000 | 0.18% | 0.00% |
| Jan. 1, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | A | Common Stock | 3867 | $0.00 | 679,591.0000 | 106,114,000 | 0.57% | 0.00% |
| Jan. 1, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Machiels Alec | Director | A | Stock Option (Right to Buy) | 7441 | $0.00 | 7,441.0000 | 106,114,000 | 9999.99% | 0.01% |